Chemical genetics: tailoring tools for cell biology.

Chemical genetics is a research approach that uses small molecules as probes to study protein functions in cells or whole organisms. Here, I review the parallels between classical genetic and chemical-genetic approaches and discuss the merits of small molecules to dissect dynamic cellular processes. I then consider the pros and cons of different screening approaches and specify strategies aimed at identifying and validating cellular target proteins. Finally, I highlight the impact of chemical genetics on our current understanding of cell biology and its potential for the future.

[1]  S. Schreiber,et al.  Printing proteins as microarrays for high-throughput function determination. , 2000, Science.

[2]  S. Haggarty,et al.  Small molecule inhibitor of mitotic spindle bipolarity identified in a phenotype-based screen. , 1999, Science.

[3]  A. Hinnen,et al.  Drug‐induced phenotypes provide a tool for the functional analysis of yeast genes , 1998, Yeast.

[4]  M. Labouesse.  [Caenorhabditis elegans]. , 2003, Medecine sciences : M/S.

[5]  M. Snapper,et al.  S-adenosylmethionine reverses ilimaquinone's vesiculation of the Golgi apparatus: a fluorescence study on the cellular interactions of ilimaquinone. , 2001, Bioorganic & medicinal chemistry letters.

[6]  T. Hsu,et al.  The effects of colcemid inhibition and reversal on the fine structure of the mitotic apparatus of Chinese hamster cells in vitro. , 1967, Journal of ultrastructure research.

[7]  A. Bridges,et al.  A synthetic inhibitor of the mitogen-activated protein kinase cascade. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[8]  Andrew W. Murray,et al.  Feedback control of mitosis in budding yeast , 1991, Cell.

[9]  T. Mitchison,et al.  Towards a pharmacological genetics. , 1994, Chemistry & biology.

[10]  D. Gottschling,et al.  Identification of a small molecule inhibitor of Sir2p , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[11]  A. Straight,et al.  A small-molecule inhibitor of skeletal muscle myosin II , 2002, Nature Cell Biology.

[12]  R. Dolle.  Comprehensive survey of combinatorial library synthesis: 2001. , 2002, Journal of combinatorial chemistry.

[13]  J. Kofron,et al.  Distinctive Roles of PHAP Proteins and Prothymosin-α in a Death Regulatory Pathway , 2003, Science.

[14]  W McDowell,et al.  Dissecting glycoprotein biosynthesis by the use of specific inhibitors☆ , 1988, Biochimie.

[15]  P G Schultz,et al.  A cyclin-dependent kinase inhibitor inducing cancer cell differentiation: biochemical identification using Xenopus egg extracts. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[16]  S. Haggarty,et al.  High-throughput screening of small molecules in miniaturized mammalian cell-based assays involving post-translational modifications. , 1999, Chemistry & biology.

[17]  C. Crews,et al.  Eponemycin exerts its antitumor effect through the inhibition of proteasome function. , 1999, Cancer research.

[18]  B. Roberts,et al.  S. cerevisiae genes required for cell cycle arrest in response to loss of microtubule function , 1991, Cell.

[19]  C. Crews,et al.  Small-molecule inhibitors of the cell cycle. , 2000, Current opinion in chemical biology.

[20]  L. Hartwell,et al.  Twenty-five years of cell cycle genetics. , 1991, Genetics.

[21]  S. Schreiber,et al.  A Mammalian Histone Deacetylase Related to the Yeast Transcriptional Regulator Rpd3p , 1996, Science.

[22]  S. Schreiber,et al.  A receptor for the immuno-suppressant FK506 is a cis–trans peptidyl-prolyl isomerase , 1989, Nature.

[23]  R. Vallee.  A taxol-dependent procedure for the isolation of microtubules and microtubule-associated proteins (MAPs) , 1982, The Journal of cell biology.

[24]  Hilla Peretz,et al.  Ju n 20 03 Schrödinger ’ s Cat : The rules of engagement , 2003 .

[25]  Timothy J. Mitchison,et al.  Probing Spindle Assembly Mechanisms with Monastrol, a Small Molecule Inhibitor of the Mitotic Kinesin, Eg5 , 2000, The Journal of cell biology.

[26]  Timothy J Mitchison,et al.  Dissecting Temporal and Spatial Control of Cytokinesis with a Myosin II Inhibitor , 2003, Science.

[27]  G. Borisy,et al.  THE MECHANISM OF ACTION OF COLCHICINE , 1967, The Journal of cell biology.

[28]  R. Klinke,et al.  A Chemical Inhibitor of p 53 That Protects Mice from the Side Effects of Cancer Therapy , 1999 .

[29]  B. Stockwell.  Chemical Genetic Screening Approaches to Neurobiology , 2002, Neuron.

[30]  Atul Butte,et al.  The use and analysis of microarray data , 2002, Nature Reviews Drug Discovery.

[31]  Kavita Shah,et al.  A Chemical-Genetic Strategy Implicates Myosin-1c in Adaptation by Hair Cells , 2002, Cell.

[32]  D. Khayat,et al.  Taxol in the Management of Cancers of the Breast and the Ovary , 2000, Cancer investigation.

[33]  Elizabeth A. Winzeler,et al.  Genomic profiling of drug sensitivities via induced haploinsufficiency , 1999, Nature Genetics.

[34]  Timothy J. Mitchison,et al.  Eg5 is static in bipolar spindles relative to tubulin , 2001, The Journal of cell biology.

[35]  Peter G. Schultz,et al.  Myoseverin, a microtubule-binding molecule with novel cellular effects , 2000, Nature Biotechnology.

[36]  M. Snapper,et al.  Photoaffinity study of the cellular interactions of ilimaquinone. , 1998, Bioorganic & medicinal chemistry.

[37]  R F Standaert,et al.  Inhibition of proteasome activities and subunit-specific amino-terminal threonine modification by lactacystin , 1995, Science.

[38]  J. Lippincott-Schwartz,et al.  Brefeldin A: insights into the control of membrane traffic and organelle structure , 1992, The Journal of cell biology.

[39]  S. Haggarty,et al.  Dissecting cellular processes using small molecules: identification of colchicine-like, taxol-like and other small molecules that perturb mitosis. , 2000, Chemistry & biology.

[40]  M V Boland,et al.  Automated recognition of patterns characteristic of subcellular structures in fluorescence microscopy images. , 1998, Cytometry.

[41]  W. Bornmann,et al.  The anti-angiogenic agent fumagillin covalently binds and inhibits the methionine aminopeptidase, MetAP-2. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[42]  C. Nüsslein-Volhard,et al.  Mutations affecting segment number and polarity in Drosophila , 1980, Nature.

[43]  J G Gleason,et al.  A small, nonpeptidyl mimic of granulocyte-colony-stimulating factor [see commetns]. , 1998, Science.

[44]  K. Bloom,et al.  The Role of Actin in Spindle Orientation Changes during the Saccharomyces cerevisiae Cell Cycle , 1999, The Journal of cell biology.

[45]  P. Schiff,et al.  Taxol stabilizes microtubules in mouse fibroblast cells. , 1980, Proceedings of the National Academy of Sciences of the United States of America.

[46]  Timothy J Mitchison,et al.  Small molecules, big impact: a history of chemical inhibitors and the cytoskeleton. , 2002, Chemistry & biology.

[47]  H. Lane,et al.  Phosphorylation by p34cdc2 regulates spindle association of human Eg5, a kinesin-related motor essential for bipolar spindle formation in vivo , 1995, Cell.

[48]  Y. Feng,et al.  Use of biomimetic diversity-oriented synthesis to discover galanthamine-like molecules with biological properties beyond those of the natural product. , 2001, Journal of the American Chemical Society.

[49]  J. Kofron,et al.  Distinctive roles of PHAP proteins and prothymosin-alpha in a death regulatory pathway. , 2003, Science.

[50]  E. Berger,et al.  Golgi-disturbing agents , 1998, Histochemistry and Cell Biology.

[51]  Anthony C. Bishop,et al.  Unnatural ligands for engineered proteins: new tools for chemical genetics. , 2000, Annual review of biophysics and biomolecular structure.

[52]  D. Boger,et al.  Small-molecule antagonists of Myc/Max dimerization inhibit Myc-induced transformation of chicken embryo fibroblasts , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[53]  R. Hertzberg,et al.  High-throughput screening: new technology for the 21st century. , 2000, Current opinion in chemical biology.

[54]  T. Mitchison,et al.  Identification of small-molecule inhibitors of interaction between the BH3 domain and Bcl-xL , 2001, Nature Cell Biology.

[55]  Thomas Young,et al.  On the Mechanism of the Eye , 1801 .

[56]  J. Ávila,et al.  Microtubule functions. , 1992, Life sciences.

[57]  Nicholas J Westwood,et al.  Using small molecules to study big questions in cellular microbiology , 2002, Cellular microbiology.

[58]  N. Munakata.  [Genetics of Caenorhabditis elegans]. , 1989, Tanpakushitsu kakusan koso. Protein, nucleic acid, enzyme.

[59]  E. Auerswald,et al.  Functional phage display of leech‐derived tryptase inhibitor (LDTI): construction of a library and selection of thrombin inhibitors , 1999, FEBS letters.

[60]  M V Chernov,et al.  A chemical inhibitor of p53 that protects mice from the side effects of cancer therapy. , 1999, Science.

[61]  P. Schiff,et al.  Promotion of microtubule assembly in vitro by taxol , 1979, Nature.

[62]  F al-Obeidi,et al.  Peptide and peptidomimetic libraries , 1998, Molecular biotechnology.

[63]  A. Murray,et al.  Localization of Mad2 to Kinetochores Depends on Microtubule Attachment, Not Tension , 1998, The Journal of cell biology.

[64]  J. Scholey,et al.  Analyzing microtubule motors in real time. , 1993, Methods in cell biology.

[65]  J. Dowling,et al.  Small molecule developmental screens reveal the logic and timing of vertebrate development. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[66]  R. Dolle.  Comprehensive survey of combinatorial library synthesis: 2000. , 2001, Journal of combinatorial chemistry.

[67]  E J Licitra,et al.  A three-hybrid system for detecting small ligand-protein receptor interactions. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[68]  P. Brown,et al.  Drug target validation and identification of secondary drug target effects using DNA microarrays , 1998, Nature Medicine.

[69]  I. Muegge.  Pharmacophore features of potential drugs. , 2002, Chemistry.